Enveric Biosciences Inc. (ENVB)
Enveric Biosciences Statistics
Share Statistics
Enveric Biosciences has 1.92M shares outstanding. The number of shares has increased by -75.33% in one year.
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | -75.33% |
| Shares Change (QoQ) | -81.2% |
| Owned by Institutions (%) | 12.4% |
| Shares Floating | 1.81M |
| Failed to Deliver (FTD) Shares | 1.16K |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 330.22K, so 3.18% of the outstanding shares have been sold short.
| Short Interest | 330.22K |
| Short % of Shares Out | 3.18% |
| Short % of Float | 3.48% |
| Short Ratio (days to cover) | 0.31 |
Valuation Ratios
The PE ratio is -0.28 and the forward PE ratio is -0.2. Enveric Biosciences's PEG ratio is 0.
| PE Ratio | -0.28 |
| Forward PE | -0.2 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 1.7 |
| P/FCF Ratio | -0.35 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Enveric Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.
| Current Ratio | 1.84 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.37M |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8.93K |
| Effective Tax Rate | 0.09% |
Stock Price Statistics
The stock price has increased by -92.34% in the last 52 weeks. The beta is 0.08, so Enveric Biosciences's price volatility has been higher than the market average.
| Beta | 0.08 |
| 52-Week Price Change | -92.34% |
| 50-Day Moving Average | 2.19 |
| 200-Day Moving Average | 5.81 |
| Relative Strength Index (RSI) | 31.6 |
| Average Volume (20 Days) | 2.86M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -9.63M |
| Net Income | -9.57M |
| EBITDA | -9.25M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -19.04 |
Balance Sheet
The company has 2.24M in cash and 0 in debt, giving a net cash position of 2.24M.
| Cash & Cash Equivalents | 2.24M |
| Total Debt | 0 |
| Net Cash | 2.24M |
| Retained Earnings | -106.07M |
| Total Assets | 4.79M |
| Working Capital | 3.5M |
Cash Flow
In the last 12 months, operating cash flow was -7.73M and capital expenditures 0, giving a free cash flow of -7.73M.
| Operating Cash Flow | -7.73M |
| Capital Expenditures | 0 |
| Free Cash Flow | -7.73M |
| FCF Per Share | -15.36 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENVB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ENVB is $10, which is 663.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 663.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jan 27, 2025. It was a backward split with a ratio of 1:15.
| Last Split Date | Jan 27, 2025 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -34.64 |
| Piotroski F-Score | 3 |